Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCGO OTCMKTS:DVCR NASDAQ:VMD NASDAQ:XGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCGODocGo$1.53-2.5%$1.53$1.23▼$5.68$153.56M0.97342,326 shs421,979 shsDVCRDiversicare Healthcare Services$10.09+1.0%$10.09$2.50▼$10.09$70.12M0.8618,931 shs49,400 shsVMDViemed Healthcare$6.78-2.0%$6.77$5.93▼$9.81$262.97M1.38218,307 shs315,330 shsXGNExagen$9.74-2.6%$8.70$2.38▼$10.34$220.04M1.6215,112 shs141,136 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCGODocGo0.00%-3.16%-6.13%+5.52%-56.78%DVCRDiversicare Healthcare Services0.00%0.00%0.00%0.00%0.00%VMDViemed Healthcare0.00%-1.45%-1.60%+1.95%-7.76%XGNExagen0.00%+0.72%+4.17%+36.80%+221.45%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCGODocGo$1.53-2.5%$1.53$1.23▼$5.68$153.56M0.97342,326 shs421,979 shsDVCRDiversicare Healthcare Services$10.09+1.0%$10.09$2.50▼$10.09$70.12M0.8618,931 shs49,400 shsVMDViemed Healthcare$6.78-2.0%$6.77$5.93▼$9.81$262.97M1.38218,307 shs315,330 shsXGNExagen$9.74-2.6%$8.70$2.38▼$10.34$220.04M1.6215,112 shs141,136 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCGODocGo0.00%-3.16%-6.13%+5.52%-56.78%DVCRDiversicare Healthcare Services0.00%0.00%0.00%0.00%0.00%VMDViemed Healthcare0.00%-1.45%-1.60%+1.95%-7.76%XGNExagen0.00%+0.72%+4.17%+36.80%+221.45%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCGODocGo 2.50Moderate Buy$3.59134.64% UpsideDVCRDiversicare Healthcare Services 0.00N/AN/AN/AVMDViemed Healthcare 0.00N/AN/AN/AXGNExagen 3.13Buy$12.0023.20% UpsideCurrent Analyst Ratings BreakdownLatest DVCR, VMD, XGN, and DCGO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/11/2025XGNExagenB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$15.009/10/2025XGNExagenB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy8/21/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$1.45 ➝ $1.607/30/2025XGNExagenCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$10.007/30/2025XGNExagenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$8.00 ➝ $11.007/30/2025XGNExagenKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSector Weight ➝ Overweight$12.007/23/2025XGNExagenCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$12.00(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCGODocGo$616.55M0.24$0.41 per share3.71$3.09 per share0.50DVCRDiversicare Healthcare Services$475.72M0.15$5.87 per share1.72($4.57) per share-2.21VMDViemed Healthcare$240.88M1.09$0.92 per share7.35$3.41 per share1.99XGNExagen$55.64M3.85N/AN/A$0.54 per share18.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCGODocGo$19.99M-$0.19N/A19.13N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)DVCRDiversicare Healthcare Services$5.16M$0.3628.03∞N/A0.53%-15.01%1.05%N/AVMDViemed Healthcare$11.27M$0.3419.94∞N/A5.80%10.38%7.88%11/5/2025 (Estimated)XGNExagen-$15.11M-$0.89N/AN/AN/A-28.85%-130.38%-34.69%11/11/2025 (Estimated)Latest DVCR, VMD, XGN, and DCGO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025DCGODocGo-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 million8/6/2025Q2 2025VMDViemed Healthcare$0.0850$0.08-$0.0050$0.08$63.50 million$63.06 million7/29/2025Q2 2025XGNExagen-$0.18-$0.18N/A-$0.21$16.25 million$17.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCGODocGoN/AN/AN/AN/AN/ADVCRDiversicare Healthcare ServicesN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/AXGNExagenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCGODocGoN/A2.362.36DVCRDiversicare Healthcare ServicesN/A0.830.83VMDViemed Healthcare0.021.481.37XGNExagen1.064.954.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCGODocGo56.44%DVCRDiversicare Healthcare Services33.14%VMDViemed Healthcare74.24%XGNExagen75.25%Insider OwnershipCompanyInsider OwnershipDCGODocGo3.80%DVCRDiversicare Healthcare Services34.30%VMDViemed Healthcare20.00%XGNExagen12.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCGODocGo4,40797.81 million94.09 millionOptionableDVCRDiversicare Healthcare Services6,0006.95 million4.57 millionNot OptionableVMDViemed Healthcare1,17938.79 million31.03 millionNot OptionableXGNExagen22022.00 million19.23 millionOptionableDVCR, VMD, XGN, and DCGO HeadlinesRecent News About These CompaniesExagen's Momentum Meets Execution Risks: Why I Choose To HOLD For NowSeptember 13 at 11:49 AM | seekingalpha.comExagen (NASDAQ:XGN) Now Covered by B. RileySeptember 13 at 8:16 AM | marketbeat.comExagen (NASDAQ:XGN) Earns Buy Rating from Analysts at B. RileySeptember 13 at 2:29 AM | americanbankingnews.comExagen (NASDAQ:XGN) Upgraded to "Strong-Buy" at B. RileySeptember 13 at 2:07 AM | americanbankingnews.comB. Riley Securities Initiates Coverage of Exagen (XGN) with Buy RecommendationSeptember 12 at 12:58 PM | msn.comExagen Inc. (NASDAQ:XGN) Receives Average Recommendation of "Buy" from AnalystsSeptember 12 at 2:40 AM | marketbeat.comExagen initiated with a Buy at B. RileySeptember 11 at 12:26 PM | msn.comBeyond The Numbers: 4 Analysts Discuss Exagen StockSeptember 11 at 12:26 PM | benzinga.comExagen Inc. (NASDAQ:XGN) Short Interest UpdateSeptember 6, 2025 | marketbeat.comStonepine Capital Management LLC Sells 155,302 Shares of Exagen Inc. $XGNAugust 26, 2025 | marketbeat.comShort Interest in Exagen Inc. (NASDAQ:XGN) Expands By 52.8%August 20, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Buy" by BrokeragesAugust 18, 2025 | marketbeat.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | gurufocus.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | globenewswire.comBTIG Sticks to Their Buy Rating for Exagen (XGN)August 2, 2025 | theglobeandmail.comExagen (XGN) Receives a Buy from Craig-HallumAugust 1, 2025 | theglobeandmail.comExagen Inc. Reports Record Revenue Amidst Growth ChallengesAugust 1, 2025 | theglobeandmail.comCanaccord Genuity Sticks to Its Buy Rating for Exagen (XGN)July 31, 2025 | theglobeandmail.comXGN | Exagen Inc. Annual Cash Flow Statement | MarketWatchJuly 31, 2025 | marketwatch.comKeybanc Upgrades Exagen (XGN)July 31, 2025 | msn.comExagen upgraded to Overweight from Sector Weight at KeyBancJuly 30, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDVCR, VMD, XGN, and DCGO Company DescriptionsDocGo NASDAQ:DCGO$1.53 -0.04 (-2.55%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.50 -0.03 (-1.63%) As of 09/12/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Diversicare Healthcare Services OTCMKTS:DVCR$10.09 +0.10 (+1.00%) As of 11/22/2021Diversicare Healthcare Services, Inc. provides post-acute care services. The firm offers services to patients and residents including skilled nursing, ancillary health care services and assisted living. It also provides long-term care centres and rehabilitative, nutritional, respiratory and other specialized ancillary services. The company was founded in 1994 and is headquartered in Brentwood, TN.Viemed Healthcare NASDAQ:VMD$6.78 -0.14 (-2.02%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$6.78 0.00 (0.00%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.Exagen NASDAQ:XGN$9.74 -0.26 (-2.60%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$10.00 +0.26 (+2.67%) As of 09/12/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
